即時科研(08119.HK)接聯交所取消上市通知
即時科研(08119.HK)公布,於2月28日接獲聯交所之函件,根據上市規則由於公司未能維持足夠業務水平及足夠價值的資產支持其業務經營,以保證股份繼續上市。根據該函件,公司須重新遵守GEM上市規則第17.26條,符合聯交所設定的任何復牌指引及全面遵守GEM上市規則致令聯交所滿意方能讓股份恢復買賣,倘股份停牌持續達12個月,聯交所可取消股份的上市。而根據上市規則公司有權提交GEM上市委員會以作覆核,倘公司於3月10日仍未作出覆核申請,股份將自3月11日上午9時正起暫停買賣,公司仍在在審閱該函件,並正與公司的專業顧問進行討論,亦會積極考慮對該決定提出覆核要求。(el/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.